![Douglas Manion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Manion
Président chez
LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC.
Fortune : 6 854 $ au 31/07/2026
Profil
Douglas J.
Manion is currently Chairman at Lakewood-Amedex Biotherapeutics, Inc. and Chairman at Lakewood-Amedex, Inc., both positions starting in 2025.
Former roles include Chief Executive Officer & Director at Flare Therapeutics, Inc. from 2024 to 2026; President, Chief Executive Officer & Director at Aclaris Therapeutics, Inc. from 2023 to 2024; Executive Vice President-Research & Development at Arena Pharmaceuticals, Inc. from 2021 to 2022; Chairman & Chief Executive Officer at Kleo Pharmaceuticals, Inc. from 2020 to 2021; Senior Vice President & Head-Specialty Development at Bristol Myers Squibb Co. from 2014 to 2016; Vice President-Clinical Development & Medical Affairs at GSK Plc from 2001 to 2005; and Non-Executive Director at Celleron Therapeutics Ltd. Education includes undergraduate and doctorate degrees from the University of Ottawa.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/04/2026 | 3 393 ( 0,19 % ) | 6 854 $ | 31/07/2026 |
Postes actifs de Douglas Manion
| Sociétés | Poste | Début |
|---|---|---|
| LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC. | Président | 12/02/2025 |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Président | 13/02/2025 |
Anciens postes connus de Douglas Manion
| Sociétés | Poste | Fin |
|---|---|---|
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur Général | 30/06/2026 |
| ACLARIS THERAPEUTICS, INC. | Directeur Général | 16/01/2024 |
| ARENA PHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/03/2022 |
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Directeur Général | 31/01/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 19/02/2013 |
Formation de Douglas Manion
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Ottawa
 University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
 Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Health Technology |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Commercial Services |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
